Safety, biodistribution, and dosimetry of 123I-IMPY: A novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease

Journal of Nuclear Medicine

Volumn 47, Issue 5, 2006, Pages 748-754

  Newberg, Andrew B ^a   Wintering, Nancy A ^a   Plössl, Karl ^a   Hochold, John ^a   Stabin, Michael G ^b   Watson, Marianne ^a   Skovronsky, Daniel ^c   Clark, Christopher M ^a   Kung, Mei Ping ^a   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c AVID RADIOPHARMACEUTICALS   (United States)

Author keywords

123I IMPY; Alzheimer's disease; Amyloid plaque; Dosimetry; Neurology; SPECT

Indexed keywords

6 IODO 2 (4' DIMETHYLAMINO)PHENYL IMIDAZO[1,2 A]PYRIDINE I 123; DONEPEZIL; PENTETIC ACID; PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 2,3 DIHYDRO 1H IMIDAZO[1,2 B]PYRAZOLE; 2,3-DIHYDRO-1H-IMIDAZO(1,2-B)PYRAZOLE; AMYLOID; DIAGNOSTIC AGENT; PYRAZOLE DERIVATIVE; RADIOACTIVE IODINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOSE RESPONSE; DOSIMETRY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; FEMALE; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIODIAGNOSIS; WHOLE BODY IMAGING; CHEMICAL MODEL; CHEMISTRY; METHODOLOGY; MIDDLE AGED; RADIOMETRY; SCINTISCANNING; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MODELS, CHEMICAL; PYRAZOLES; RADIOMETRY; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 33745534523     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ginsberg SD, Schmidt ML, Crino PB, Eberwine JH, Lee VM-Y, Trojanowski JQ. Molecular pathology of Alzheimer's disease and related disorders. In: Peters A, Morrison JH, eds. Cerebral Cortex: Neurodegenerative and Age-Related Changes in Structure and Function of Cerebral Cortex. New York, NY: Kluwer Academic/Plenum; 1999:603-654.
2. Selkoe DJ. The origins of Alzheimer disease: A is for amyloid. JAMA. 2000;283:1615-1617.
3. Selkoe DJ. Imaging Alzheimer's amyloid. Nat Biotechnol. 2000;18:823-824.
4. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353-356.
5. 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem. 2003;46:2740-2754.
6. Mathis CA, Wang Y, Klunk WE. Imaging β-amyloid plaques and neurofibrillary tangles in the aging human brain. Curr Pharm Des. 2004;10:1469-1492.
7. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306-319.
8. Ono M, Kung M-P, Hou C, Kung HF. Benzofuran derivatives as Aβ-aggregate-specific imaging agents for Alzheimer's disease. Nucl Med Biol. 2002;29:633-642.
9. Wilson A, Nobrega J, Houle S, et al. Radiosynthesis and evaluation of potential β-amyloid imaging radiotracer for PET [abstract]. J Labelled Compds Radiopharm. 2003;46(suppl):S61.
10. Agdeppa ED, Kepe V, Shoghi-Jadid K, et al. In vivo and in vitro labeling of plaques and tangles in the brain of an Alzheimer's disease patient: a case study [abstract]. J Nucl Med. 2001;42(suppl):65P.
11. Shoghi-Jadid K, Small GW, Agdeppa ED, et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease: binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer disease. Am J Geriatr Psychiatry. 2002;10:24-35.
12. Zhuang Z-P, Kung M-P, Hou C, et al. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J Med Chem. 2001;44:1905-1914.
13. Kung HF, Lee C-W, Zhuang ZP, et al. Novel stilbenes as probes for amyloid plaques. J Am Chem Soc. 2001;123:12740-12741.
14. Lee C-W, Kung M-P, Hou C, Kung HF. Dimethylamino-fluorenes: ligands for detecting β amyloid plaques in the brain. Nucl Med Biol. 2003;30:573-580.
15. Kung MP, Hou C, Zhuang ZP, et al. Characterization of IMPY as a potential imaging agent for b-amyloid plaques in double transgenic PSAPP mice. Eur J Nucl Med Mol Imaging. 2004;31:1136-1145.
16. Kung MP, Hou C, Zhuang ZP, et al. IMPY: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques. Brain Res. 2002;956:202-210.
17. Zhuang ZP, Kung MP, Wilson A, et al. Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain. J Med Chem. 2003;46:237-243.
18. Sorenson JA, Phelps ME. Internal radiation dosimetry. In: Physics in Nuclear Medicine. 2nd ed. Philadelphia, PA: W.B. Saunders; 1987:197-218.
19. Newberg AB, Plössl K, Mozley PD, et al. Biodistribution and imaging with I-123 ADAM: a serotonin transporter imaging agent. J Nucl Med. 2004;45:834-841.
20. Mozley PD, Zhu XW, Kung HF, et al. The dosimetry of 3-iodo-Schering 23390: quantification of the radiation burden to healthy humans. J Nucl Med. 1993;34:208-213.
21. Mozley PD, Stubbs JS, Kung HF, et al. Biodistribution and dosimetry of I-123 IBF: a potent radioligand for imaging the D2 dopamine receptor. J Nucl Med. 1993;34:1910-1917.
22. Mozley PD, Stubbs JB, Kim H-J, et al. Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT. J Nucl Med. 1995;36:1322-1331.
23. Mozley PD, Stubbs JB, Kim H-J, et al. Dosimetry of an iodine-123-labeled tropane to image dopamine transporters. J Nucl Med. 1996;37:151-159.
24. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer' Disease. Neurology. 1984;34:939-944.
25. Cloutier RJ, Smith SA, Watson EE, et al. Dose to the fetus from radionuclides in the bladder. Health Phys. 1973;25:147-161.
26. Loevinger R, Budinger TF, Watson EE. MIRD Primer for Absorbed Dose Calculations. New York, NY: Society of Nuclear Medicine; 1988.
27. Toohey RE, Stabin MG. Comparative analysis of dosimetry parameters for nuclear medicine. In: Proceedings of the 6th International Radiopharmaceutical Dosimetry Symposium; May 7-10, 1996; Gatlinburg, TN.
28. 123IFP-CIT: a potent radioligand for imaging the dopamine transporters. Eur J Nucl Med. 1998;25:24-30.
29. Verhoeff NP, Sokole EB, Stabin M, et al. Dosimetry of iodine-123 iobenzamide in healthy volunteers. Eur J Nucl Med. 1993;20:747-752.